0001562180-19-003078.txt : 20190523
0001562180-19-003078.hdr.sgml : 20190523
20190523172611
ACCESSION NUMBER: 0001562180-19-003078
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190521
FILED AS OF DATE: 20190523
DATE AS OF CHANGE: 20190523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sandor Victor
CENTRAL INDEX KEY: 0001620368
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16633
FILM NUMBER: 19851204
MAIL ADDRESS:
STREET 1: C/O ARRAY BIOPHARMA INC.
STREET 2: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC
CENTRAL INDEX KEY: 0001100412
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841460811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 3033816600
MAIL ADDRESS:
STREET 1: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-05-21
false
0001100412
ARRAY BIOPHARMA INC
ARRY
0001620368
Sandor Victor
C/O ARRAY BIOPHARMA INC.
3200 WALNUT STREET
BOULDER
CO
80301
false
true
false
false
Chief Medical Officer
Common Stock
2019-05-21
4
M
false
12600.00
3.65
A
250292.00
D
Common Stock
2019-05-21
4
S
false
12600.00
26.50
D
237692.00
D
Stock Option (Right to Buy)
3.65
2019-05-21
4
M
false
12600.00
0.00
D
2024-09-22
Common Stock
12600.00
139262.00
D
These trades were made pursuant to a Rule 10b5-1 trading plan.
The option vested in four equal annual installments beginning on September 22, 2015.
Jason Haddock, attorney-in-fact for Victor Sandor
2019-05-23